Migraine Management: New Therapeutic Options to Reduce Migraine Pain

By Teshamae Monteith, MD, FAHS
Chief, Headache Division
Fellowship Program Director
Associate Professor of Clinical Neurology
Department of Neurology
University of Miami, Miller School of Medicine
Miami, FL

Teshamae Monteith, MD, FAHS is an Associate Professor of Clinical Neurology at the University of Miami, Miller School of Medicine. After graduating with a medical degree from the Miller School of Medicine, Dr. Monteith completed a neurology residency at New York University and pursued two fellowships in headache medicine at Thomas Jefferson University and the University of California, San Francisco. She is currently the Chief of the Headache Division and Director of the Headache Fellowship.

Dr. Monteith is a recipient of the American Academy of Neurology’s (AAN) Palatucci Advocacy Leadership Award and the American Headache Society’s Wolff Award. She is a highly regarded lecturer, author of numerous publications, and has served on a number of advisory boards, including industry boards and for the AAN’s Brain and Life magazine. She conducts a number of clinical trials in the management of headache and has been funded by the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) to promote diversity in health‐related research and work in migraine, stroke, and imaging biomarkers. She is the Chair of the American Academy of Pain Medicine Foundation’s workgroup for “Guidelines on Preventive Multidisciplinary Management of Migraine.”

Presentation Materials